Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Business13 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
Noosa News11 hours agoGaming policy on council’s agenda
-
Business14 hours agoWhere to invest $10,000 in ASX ETFs this December
-
General9 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism